Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Conditions: COVID-19; Deep Vein Thrombosis; Anticoagulants and Bleeding Disorders; Critical Illness Interventions: Drug: Enoxaparin; Drug: Heparin Sponsor: University Hospital, Ghent Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials